Merck KGaA, Darmstadt, Germany

Merck KGaA, Darmstadt, Germany provides over 300,000 products focused on scientific discovery, biomanufacturing, and testing services. Their expertise includes developing molecular tools, labware, sample prep, antibodies, cell culture, live cell analysis, biochemicals, and biomarker immunoassays for research, diagnostics, and therapeutics.

The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada.

About Us

Marketing

Bitesize Bio Search

Merck KGaA, Darmstadt, Germany

Sponsored Content

CRISPR Unlocked: Optimizing Gene Editing Experimental Design

Winning Westerns: Optimize the Full Electrophoresis and Blotting Workflow

Inside Immunoassays: Capturing Biomarkers Below the Radar with Femtogram Resolution

Your Ultimate Guide to Ultrafiltration: Basics, Membranes, and Applications

Inside Immunoassays: Boost Assay Efficiency with Smart Design and Analysis

Detecting Rare T-Cell Responses at Scale with ELISpot and FluoroSpot

Versatile Planar Chromatography Techniques for Biological Research

Inside Immunoassays: Strategies to Maximize Your Immunoassay Data and Insights

Protein Conjugation Methods for Antibody and Antibody Fragment Production

Pioneering Biomarker Discovery In Mucinomics Through Mass Spectrometry

Analyte Binding Following Sample Filtration in HPLC

Assay Development for Quantification of Low-abundance Proteins Using Single Molecule Counting

Pioneering Biomarker Discovery In Mucinomics Through Mass Spectrometry

Multiplexing Magic: How MULTI-seq Revolutionizes Single-Cell RNA Sequencing

Inside Immunoassays: Best Practices for Accurate and Reliable Results

Culture Media Preparation: Contamination Control and Retention of Critical Components

Using Multiplex Bioassays to Profile Biomarkers of Precursors to Pancreatic Cancer

Unleash New Biological Insights with Innovative Glycoanalytics

Contamination and Recovery of PFAS in Analytical Methods Requiring Filter Membranes

Using Antisense to Characterize Nonsense: A Mouse Model of Progranulin-Deficient Dementia

Jump into 3D Organoids: Basic Culture Techniques and Advanced Applications

miRNA as a Novel Toxicity Biomarker

Measuring Beyond the Limitations of ELISAs

Understanding Gum Diseases by Integrating Multiplexed-technologies in the Microbiome and Immunological Analysis

Advances in High-Throughput Drug Screening Using TrueGel3D® HTS Hydrogel 3D Cell Culture Plates

Detecting Low-Abundant Neurofilament Light Chain

RNA Interference - From Single Gene Studies to Whole Genome Screens

Cytokine Analysis in Non-Human Primates

Immunoassay Verification and Quality Control Practices and How They Affect Data Outputs

IL-13 is a Pathogenic Driver of COVID-19

Advances to SYNTHIA™ Retrosynthesis Software and How They Have Accelerated Chemical Development at GlaxoSmithKline (GSK)

Development of Ultrasensitive Immunoassays for SARS-CoV-2 Antibody Detection

The End of the Beginning for Retrosynthetic Planning

Immune Responses in Severe Covid-19 Patients

IgG Antibodies Against SARS-CoV-2 Correlate to Days from Symptom Onset in COVID-19 Positive Patients

A Complete Reference for Better Pipetting

Live Webinar – April 7: Applying Cell Sorting in Clinical Immunology Research